Approvals/TGA/BTC DESVENLAFAXINE desvenlafaxine 50 mg extended release tablet blister pack

Approved

STANDARD

BTC DESVENLAFAXINE desvenlafaxine 50 mg extended release tablet blister pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6c2ea553eadf0e59
Product Name: BTC DESVENLAFAXINE desvenlafaxine 50 mg extended release tablet blister pack
Artg Id: 425290
Artg Name: BTC DESVENLAFAXINE desvenlafaxine 50 mg extended release tablet blister pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2023-12-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/19c55d43c67de69862f7c0c448b5e601.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/17b1f26bfe6d4e209ad8c87f17c291f0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

6c2ea553eadf0e59

Type

Standard